SA
INSM icon

Seneschal Advisors’s Insmed INSM Stock Holding History

Seneschal Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107 Hold
1
– – ﹤0.01% 576
2026
Q1 		$164 Hold
1
– – ﹤0.01% 545
2025
Q4 		$175 Hold
1
– – ﹤0.01% 540
2025
Q3 		$145 Buy
+1
New +$123 ﹤0.01% 555

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Seneschal Advisors's INSM Position: Q2 2026 in Review

Seneschal Advisors held its Insmed (INSM) position steady in Q2 2026 at 1 share worth $107. The position accounts for ﹤0.01% of the portfolio, ranked #576.

Seneschal Advisors first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $175 in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Seneschal Advisors held 1 share of Insmed worth $107 as of Q2 2026.
  • Seneschal Advisors left its Insmed share count unchanged in Q2 2026.
  • Insmed made up ﹤0.01% of Seneschal Advisors's portfolio in Q2 2026, its #576 holding.
  • Seneschal Advisors first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • Seneschal Advisors's Insmed position peaked at $175 in Q4 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.